Phycom BV announced that it has received more than ?9 million in a round of funding on September 5, 2023. The transaction included participation from new investors Corbion N.V., Phase2.Earth, Invest-NL and Invest International BV.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.94 EUR | -0.48% | +8.61% | +8.05% |
Apr. 26 | Transcript : Corbion N.V., Q1 2024 Earnings Call, Apr 26, 2024 | |
Apr. 17 | Evotec Names First Chief People Officer | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.05% | 1.33B | |
+14.70% | 65.04B | |
-1.61% | 47.76B | |
+14.58% | 40.72B | |
+20.84% | 26.88B | |
+1.16% | 17.53B | |
-21.87% | 16.03B | |
+1.11% | 15.17B | |
-11.34% | 15.06B | |
-20.82% | 13.62B |
- Stock Market
- Equities
- CRBN Stock
- News Corbion N.V.
- Phycom BV announced that it has received ?9 million in funding from Corbion N.V., Phase2.Earth, Invest-NL, Invest International BV